This project is part of a larger on-going study into Small Vessel Disease (SVD) after stroke. It will allow the researchers to invite some of the participants in this project back for more frequent brain scans and tests to help them to understand more about SVD after stroke.
Small Vessel Disease (SVD) is a condition that affects the small blood vessels in the brain, and it can lead to stroke and dementia. This research programme hopes to increase our understanding of how SVD develops, leading to new ways to investigate SVD and test drugs which may help treat it.
Co-funded by the Stroke Association, the only project of its kind anywhere that studies all acute vascular events, such as strokes and heart attacks, to develop better treatments has recruited its 10,000th Oxfordshire participant.
At this week's UK Assembly North event in Nottingham, we heard from two eminent figures from the stroke research community. Professor Avril Drummond spoke about research into fatigue after stroke. Professor Joanna Wardlaw CBE spoke about the link between stroke and 'vascular dementia'.
Can using a tissue sample from the buttock help us understand the main genetic cause of stroke?
The Stroke Association's Keynote Lecture is a prestigious event which showcases the latest advancements being made in stroke research.
Find out more about our 2016 Keynote Lecture.
Using genetics to understand why disease of the small blood vessels in the brain occurs.
Problems of mood, thinking and memory are common after a stroke. There has been limited research around these issues. This work aims to answer fundamental questions around who develops these problems and how they recover.
Stroke survivors and healthcare professionals have identified psychological and cognitive (thinking and mood) problems after stroke as someof the most important areas where more research is needed. This Lectureship will investigate how common these issues are after stroke, how they change over time, and how these changes can be predicted.
Published in the journal Age and Ageing, a new systematic review of the current research suggests that anticoagulant drugs may have cognitive benefit for those with AF (atrial fibrillation).